Biosynex Share Price OTC Markets
Stocks
BSYXF
FR0011005933
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 11/06 | Triple update for Biosynex |  |
| 11/06 | An undisclosed buyer acquired Entire internal molecular biology business from Biosynex SA for ?4 million. | CI |
| Market Cap | 1.7Cr 1.95Cr 1.58Cr 1.45Cr 2.74Cr 186.21Cr 2.78Cr 19Cr 7.3Cr 93Cr 7.33Cr 7.17Cr 310.86Cr | P/E 2024 |
-0.43x | P/E 2025 | -0.19x |
|---|---|---|---|---|---|
| Enterprise Value | 7.01Cr 8.07Cr 6.53Cr 5.99Cr 11Cr 770.31Cr 11Cr 77Cr 30Cr 383.49Cr 30Cr 30Cr 1.29TCr | EV / Sales 2024 |
0.71x | EV / Sales 2025 | 0.68x |
| Free-Float |
40.35% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Larry Abensur
CEO | Chief Executive Officer | 71 | 24/06/2015 |
Thierry Paper
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/01/2015 |
Oren Bitton
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Paper
BRD | Director/Board Member | 63 | 24/06/2015 |
Thomas Lamy
BRD | Director/Board Member | - | 24/06/2015 |
Larry Abensur
CHM | Chairman | 71 | 24/06/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.95Cr | |
| +6.33% | +9.95% | +295.29% | +315.15% | 2.17TCr | |
| -3.83% | -1.14% | -45.07% | -29.17% | 937.61Cr | |
| -1.35% | -4.94% | +39.96% | +15.20% | 648.72Cr | |
| -4.37% | +2.16% | +251.45% | -24.94% | 600.12Cr | |
| -1.81% | -0.93% | -13.78% | -15.42% | 556.82Cr | |
| -2.61% | +0.97% | -44.20% | - | 442.96Cr | |
| +4.21% | +7.67% | -16.15% | -29.58% | 438.13Cr | |
| +9.99% | +1.30% | +75.99% | +91.71% | 425.07Cr | |
| -1.02% | +5.24% | -16.77% | -40.86% | 280.1Cr | |
| Average | +0.55% | +1.66% | +58.53% | +35.26% | 722.6Cr | |
| Weighted average by Cap. | +1.59% | +3.42% | +118.36% | +108.67% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10Cr 12Cr 9.42Cr 8.65Cr 16Cr 1.11TCr 17Cr 111Cr 44Cr 553.08Cr 44Cr 43Cr 1.85TCr | 9.52Cr 11Cr 8.86Cr 8.14Cr 15Cr 1.05TCr 16Cr 104.44Cr 41Cr 520.42Cr 41Cr 40Cr 1.75TCr |
| Net income | -4.33Cr -4.98Cr -4.03Cr -3.7Cr -6.99Cr -475.84Cr -7.1Cr -48Cr -19Cr -236.89Cr -19Cr -18Cr -794.35Cr | -5.82Cr -6.7Cr -5.42Cr -4.98Cr -9.4Cr -639.38Cr -9.54Cr -64Cr -25Cr -318.31Cr -25Cr -25Cr -1.07TCr |
| Net Debt | 5.29Cr 6.09Cr 4.93Cr 4.52Cr 8.54Cr 581.31Cr 8.68Cr 58Cr 23Cr 289.4Cr 23Cr 22Cr 970.4Cr | 5.32Cr 6.12Cr 4.95Cr 4.55Cr 8.58Cr 584.1Cr 8.72Cr 58Cr 23Cr 290.79Cr 23Cr 22Cr 975.06Cr |
Employees
397
- Stock Market
- Stocks
- ALBIO Stock
- BSYXF Stock
Select your edition
All financial news and data tailored to specific country editions
